IngredientesLa glicitina es un glucósido de isoflavona de origen vegetal que se encuentra principalmente en la soja (Glycine max) y otras legumbres. Es la forma glicosilada de la gliciteína, lo que significa que consiste en la aglicona isoflavona gliciteína unida a una molécula de azúcar. Una vez ingerida, la glicitina es convertida por las bacterias intestinales en gliciteína, que es la forma biológicamente activa. Como parte del trío de isoflavonas de soja—junto con la genistina (genisteína) y la daicina (daidzeína)—la glicitina contribuye a los efectos fitoestrogénicos, antioxidantes y protectores de los huesos asociados con el consumo de soja.
Aunque está presente en concentraciones más bajas que la genistina o la daicina, la glicitina desempeña un papel complementario en la modulación de los receptores de estrógenos, particularmente el receptor de estrógeno beta (ERβ), y puede ayudar a regular el equilibrio hormonal, apoyar el metabolismo óseo y proteger contra el estrés oxidativo. La glicitina también ha mostrado potencial para promover la síntesis de colágeno, lo que puede favorecer la elasticidad de la piel y el antienvejecimiento cuando se toma de manera constante como parte de un suplemento de isoflavonas de soja de espectro completo.
La investigación moderna sugiere que la glicitina y su aglicona gliciteína pueden tener efectos antiinflamatorios, neuroprotectores y antiosteoporóticos, especialmente en mujeres posmenopáusicas. Se encuentra comúnmente en productos de soja fermentada, como el tempeh y el miso, ya que la fermentación mejora la biodisponibilidad de las isoflavonas.
Uso Histórico
Aunque la glicitina como compuesto aislado solo fue identificada en el siglo XX, sus fuentes alimentarias—particularmente la soja y los productos de soja fermentada—han sido consumidas durante miles de años en las culturas del este de Asia, donde se creía que promovían la longevidad, la vitalidad y la armonía hormonal. En la Medicina Tradicional China, la soja fue clasificada como neutra, nutritiva y desintoxicante, y los alimentos de soja fermentada eran apreciados por apoyar la digestión, la salud de la sangre y la función reproductiva femenina.
En las prácticas ayurvédicas, las legumbres se usaban en formulaciones para apoyar la salud femenina, la fortaleza ósea y la regeneración de tejidos, aunque el concepto de isoflavonas aún no era conocido. Los beneficios funcionales atribuidos a estos alimentos se alinean con lo que ahora se comprende sobre la contribución de la glicitina a la modulación hormonal y la defensa antioxidante.
Hoy en día, la glicitina sigue siendo un componente sutil pero importante en los beneficios de la nutrición y la suplementación a base de soja, particularmente en productos estandarizados para el contenido total de isoflavonas. A medida que continúa la investigación sobre los fitoestrógenos y el apoyo hormonal de origen vegetal, la glicitina es reconocida como un compuesto suave modulador de estrógenos con funciones en la densidad ósea, la salud de la piel y la resiliencia celular—especialmente para quienes atraviesan la menopausia o el envejecimiento.
Condiciones de salud que cafeína puede ayudar a apoyar.
Caffeine demonstrates antioxidant properties in vitro and has been linked via Nrf-2 pathway activation to reduced oxidative stress in preclinical models. Reviews confirm caffeine's role as a non-selective adenosine receptor antagonist with antioxidant and anti-inflammatory properties. Human clinical evidence for antioxidant benefit specific to isolated caffeine (vs. whole coffee) remains limited.
Caffeine has well-documented anxiogenic effects, particularly at higher doses, supported by multiple clinical trials and meta-analyses. It acts by blocking adenosine receptors, increasing sympathetic tone and circulating catecholamines. A 2024 PMC meta-analysis found that high-dose caffeine (≥400 mg/day) significantly elevated anxiety risk (SMD=2.86) compared to lower doses. Reducing caffeine intake has been associated with improvements in anxiety symptoms in clinical practice.
Caffeine transiently suppresses appetite and increases thermogenesis via adenosine receptor antagonism and sympathetic nervous system activation. Clinical evidence shows weak to moderate appetite effects as a standalone, with more consistent outcomes in combination with green tea catechins. A systematic review confirmed caffeine enhances thermogenesis, fat oxidation, and appetite suppression.
Caffeine is a weak bronchodilator chemically related to theophylline and has demonstrated measurable improvements in lung function in people with asthma. A Cochrane systematic review confirmed that caffeine modestly improves lung function for up to four hours in asthma patients. Its effect on airway reactivity is sufficient to confound pulmonary function testing.
Caffeine is one of the best-supported ergogenic aids, with systematic reviews and meta-analyses confirming performance improvements at 3–6 mg/kg body mass. It consistently improves endurance, power output, sprint performance, and perceived exertion across multiple sports. It acts primarily via adenosine receptor antagonism in the central nervous system.
Caffeine enhances selective attention and reduces reaction time errors in healthy adults, and animal model systematic reviews show improved ADHD-like symptoms of inattention. Human clinical evidence in diagnosed ADHD populations remains limited, with most support coming from preclinical models and observational data. Caffeine is sometimes used informally by individuals with ADHD but is not a licensed treatment.
Caffeine acutely raises systolic and diastolic blood pressure by increasing sympathetic tone and peripheral vascular resistance via adenosine receptor blockade. The effect is well-established in controlled trials, with doses equivalent to 2–3 cups of coffee (200–300 mg) producing measurable pressor responses. Habitual users develop partial tolerance, and individual response is modulated by CYP1A2 genotype.
Caffeine acutely reduces symptoms consistent with brain fog—including impaired alertness, slow cognition, and poor concentration—by blocking adenosine receptors and increasing dopaminergic and noradrenergic signaling. A large UK Biobank study (up to 434,900 participants) found that recent caffeine drinking was associated with better performance on multiple cognitive tasks. However, excessive intake or withdrawal can paradoxically worsen cognitive clarity.
Caffeine is among the best-evidenced substances for acutely reducing fatigue and improving alertness, recognized across extensive clinical research. It acts as an adenosine receptor antagonist, blocking fatigue signals in the central nervous system. Multiple systematic reviews confirm its efficacy for reducing perceived fatigue and increasing vigilance and alertness.
Multiple prospective epidemiological studies and systematic reviews associate moderate caffeine intake (~200–300 mg/day) with a reduced risk of cognitive decline, mild cognitive impairment (MCI), and Alzheimer's disease (AD), though results are mixed and no randomized controlled trials exist. Caffeine's primary mechanism is antagonism of adenosine A2A receptors, which modulates neuroinflammation and reduces amyloid-beta burden in preclinical models. The evidence is promising but not yet conclusive enough to support a public health recommendation.
Topical caffeine is a well-documented vasoconstrictor that reduces blood pooling under the thin periorbital skin, diminishing the appearance of dark circles and puffiness. A randomized, double-blind, placebo-controlled study demonstrated that a caffeine-based gel reduced lower eyelid oedema and pigmentation. A 12-week clinical trial of an eye cream containing 0.2% caffeine showed statistically significant improvements in dark circles and puffiness versus baseline.
Moderate caffeine intake has been associated in observational and meta-analytic evidence with a reduced risk of depression, via adenosine antagonism that modulates dopaminergic and serotonergic systems. A 2025 PMC comprehensive review concluded that low-to-moderate caffeine may reduce depression risk and improve general mental health. High intake may have the opposite effect.
Caffeine is one of the most extensively studied ergogenic aids. It acts as an adenosine receptor antagonist, reducing perceived fatigue and enhancing alertness and physical performance. Meta-analyses confirm it improves exercise completion time by approximately 3.6% and significantly increases energy expenditure. It is widely recognized by sports nutrition bodies as an effective energy-boosting agent.
Caffeine is the world's most widely studied psychoactive substance for focus and alertness. It blocks adenosine receptors (A1 and A2a), increasing dopaminergic and cholinergic transmission, producing dose-dependent improvements in sustained attention, vigilance, reaction time, and working memory. EFSA has recognized a cause-and-effect relationship between caffeine and improved alertness and concentration.
Topical caffeine has been studied in human in vitro and clinical settings for androgenetic alopecia. It counteracts testosterone-induced suppression of hair follicle growth, stimulates hair shaft elongation in organ culture, and a clinical study found topical caffeine solution non-inferior to 5% minoxidil solution over 24 weeks. It is used in various topical hair loss products.
Caffeine enhances the analgesic efficacy of aspirin, acetaminophen, and ibuprofen for headache and is an FDA-recognized adjuvant in combination headache medications. It acts as an adenosine receptor antagonist, producing vasoconstriction that counteracts migraine-associated vasodilation. All treatment studies in a systematic review found caffeine safe and effective for acute migraine in combination.
Caffeine is a well-established thermogenic and lipolytic agent that increases resting metabolic rate and fat oxidation. The NIH ODS recognizes caffeine as one of few weight-loss supplement ingredients with credible evidence. Meta-analyses confirm modest but significant reductions in body weight, particularly when combined with other ingredients like green tea catechins.
Caffeine has complex, dose-dependent, and genotype-modulated effects on heart health. Acute intake transiently raises blood pressure and heart rate; habitual moderate consumption is generally not associated with increased cardiovascular disease risk in most epidemiological studies. Caffeine blocks adenosine receptors in coronary arteries, reducing adenosine-mediated vasodilation and potentially impairing myocardial blood flow response to exercise in at-risk individuals.
Caffeine is one of the most robustly evidenced causes of sleep disruption. By blocking adenosine receptors, it delays sleep onset, reduces total sleep time, increases nocturnal awakenings, and suppresses slow-wave sleep. These effects are well-established in controlled trials and are dose- and timing-dependent.
Caffeine is recognized by the CDC and peer-reviewed sources as a pharmacological countermeasure for jet lag-related daytime fatigue and impaired alertness. A Cochrane systematic review of 13 randomized trials found caffeine improved cognitive performance in persons with jet lag or shift-work disorder. A double-blind RCT using slow-release caffeine (300 mg) after a 7-time-zone flight demonstrated significantly reduced objective daytime sleepiness versus placebo. Caffeine functions as an adenosine-receptor antagonist, blocking sleep-promoting adenosine signaling to sustain wakefulness.
Caffeine is an adenosine receptor antagonist and the world's most widely used psychoactive substance, with centuries of traditional use in tea, coffee, and cacao. It reliably improves alertness, attention, reaction time, and cognitive processing speed in numerous controlled trials. Evidence consistently supports its acute role in enhancing mental clarity and performance.
Topical caffeine inhibits phosphodiesterase, raises cyclic AMP in follicular keratinocytes, and counteracts DHT-induced growth suppression, prolonging the anagen phase. A 2025 double-blind, placebo-controlled 24-week RCT (Celleno et al., PMC12359291) with a caffeine-containing shampoo showed significantly fewer hairs pulled (−2.8 vs +0.6, P<0.001) and improved phototrichogram parameters in male AGA versus placebo.
Caffeine acutely enhances aspects of memory performance—particularly working memory and attention-dependent memory tasks—via adenosine receptor blockade and downstream dopaminergic enhancement. The large UK Biobank study found better prospective and paired-associate memory in recent caffeine users. Effects are dose-dependent and context-dependent, with chronic high-dose use potentially impairing hippocampal working memory.
Caffeine is one of the most extensively studied psychoactive compounds for mental energy and alertness. EFSA concluded that a 75 mg serving increases both selective and sustained attention. Multiple meta-analyses confirm improvements in reaction time, accuracy, and sustained vigilance, including during sleep deprivation.
Caffeine has well-documented, clinically measured effects on human metabolism, primarily by increasing resting metabolic rate (RMR) and stimulating thermogenesis. Multiple human RCTs and controlled studies show acute caffeine ingestion raises RMR by approximately 3–12% for several hours, depending on dose and population. It also promotes lipolysis and fat oxidation, though the magnitude of these effects is attenuated in obese individuals and habitual caffeine users.
Caffeine has a dual role in migraine: low doses serve as an analgesic adjuvant and are present in several approved combination migraine treatments, while chronic high intake is associated with migraine chronification and medication-overuse headache. Caffeine abstinence has been shown in a prospective study to improve acute migraine treatment efficacy.
Caffeine stimulates mitochondrial oxidative metabolism and has been identified as a micronutrient that supports the electron transfer system function in mitochondria. It inhibits phosphodiesterase, raising cAMP levels, which activates PKA and promotes mitochondrial fatty acid oxidation and energy production.
Caffeine has documented effects on post-exercise muscle recovery, including enhanced glycogen resynthesis and potential attenuation of exercise-induced muscle damage markers. A randomized clinical trial in endurance athletes found coffee consumption post-exercise improved muscle glycogen recovery. Its ergogenic classification by the International Olympic Committee reflects a broad evidence base for performance and recovery.
Caffeine has been used to manage excessive daytime sleepiness (EDS) in narcolepsy since at least 1925, making it among the earliest documented narcolepsy treatments. A 2020 double-blind, randomized, placebo-controlled pilot trial evaluated 200 mg caffeine daily as add-on therapy in narcolepsy patients, assessing drowsiness objectively and subjectively. Caffeine acts by blocking adenosine A1 and A2A receptors, promoting vigilance, but is less potent than prescription wakefulness agents.
At least six large prospective epidemiological studies have established an inverse association between caffeine consumption and risk of developing Parkinson's disease. The mechanism involves A2A adenosine receptor antagonism, which may confer neuroprotection against dopaminergic neurodegeneration. Clinical evidence for slowing disease progression is emerging but not yet conclusive.
Caffeine is one of the most extensively researched and IOC-recognized ergogenic aids, shown across dozens of RCTs and meta-analyses to improve endurance, reduce perceived exertion, and delay fatigue. It acts centrally via adenosine receptor antagonism and peripherally on muscle metabolism. Effective doses are typically 3–6 mg/kg body weight taken ~60 min before exercise.
Caffeine is the most extensively studied thermogenic agent, consistently shown to increase resting metabolic rate (RMR) by 3–11% in controlled human trials. It stimulates the central nervous system, enhances fat oxidation, and inhibits phosphodiesterase, raising cAMP and promoting lipolysis. Studies use 100–300 mg/day to demonstrate metabolic effects.
Caffeine is a well-established mild diuretic that acts by inhibiting renal tubular sodium and water reabsorption and by blocking adenosine receptors, increasing urine output. It is recognized as a natural diuretic in peer-reviewed literature and is an ingredient in OTC PMS and water-retention formulas. Green tea, black tea, coffee, and guarana are all recognized as diuretics primarily due to their caffeine content.
Sistemas corporales que cafeína puede ayudar a apoyar.
Volver